Tag Archives: postmarket

OIG: FDA needs to address postmarket cybersecurity risk to medical devices

The Food and Drug Administration’s policies and procedures are not sufficient for effectively dealing with postmarket medical device cybersecurity events, an emerging risk to public health and the FDA’s mission. That’s the finding of an audit by the Department of Health and Human Services’ Office of Inspector General. The FDA regulates medical devices in two… Read More »